IRIS Accounts Production v17.3.1.106 SC053605 Board of Directors 1.10.16 30.9.17 30.9.17 false true false false false true false Fair value model Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureSC0536052016-09-30SC0536052017-09-30SC0536052016-10-012017-09-30SC0536052015-09-30SC0536052015-10-012016-09-30SC0536052016-09-30SC053605ns15:Scotland2016-10-012017-09-30SC053605ns14:PoundSterling2016-10-012017-09-30SC053605ns10:Director12016-10-012017-09-30SC053605ns10:PrivateLimitedCompanyLtd2016-10-012017-09-30SC053605ns10:SmallEntities2016-10-012017-09-30SC053605ns10:AuditExemptWithAccountantsReport2016-10-012017-09-30SC053605ns10:SmallCompaniesRegimeForDirectorsReport2016-10-012017-09-30SC053605ns10:SmallCompaniesRegimeForAccounts2016-10-012017-09-30SC053605ns10:FullAccounts2016-10-012017-09-30SC05360512016-10-012017-09-30SC053605ns10:OrdinaryShareClass12016-10-012017-09-30SC053605ns10:Director22016-10-012017-09-30SC053605ns10:Director32016-10-012017-09-30SC053605ns10:Director42016-10-012017-09-30SC053605ns10:Director52016-10-012017-09-30SC053605ns10:Director62016-10-012017-09-30SC053605ns10:CompanySecretary12016-10-012017-09-30SC053605ns10:RegisteredOffice2016-10-012017-09-30SC053605ns5:CurrentFinancialInstruments2017-09-30SC053605ns5:CurrentFinancialInstruments2016-09-30SC053605ns5:ShareCapital2017-09-30SC053605ns5:ShareCapital2016-09-30SC053605ns5:FurtherSpecificReserve1ComponentTotalEquity2017-09-30SC053605ns5:FurtherSpecificReserve1ComponentTotalEquity2016-09-30SC053605ns5:RetainedEarningsAccumulatedLosses2017-09-30SC053605ns5:RetainedEarningsAccumulatedLosses2016-09-30SC053605ns5:IntangibleAssetsOtherThanGoodwill2016-10-012017-09-30SC053605ns5:PatentsTrademarksLicencesConcessionsSimilar2016-10-012017-09-30SC053605ns5:LandBuildings2016-10-012017-09-30SC053605ns5:PlantMachinery2016-10-012017-09-30SC053605ns5:IntangibleAssetsOtherThanGoodwill2016-09-30SC053605ns5:IntangibleAssetsOtherThanGoodwill2017-09-30SC053605ns5:IntangibleAssetsOtherThanGoodwill2016-09-30SC053605ns5:LandBuildings2016-09-30SC053605ns5:PlantMachinery2016-09-30SC053605ns5:LandBuildings2017-09-30SC053605ns5:PlantMachinery2017-09-30SC053605ns5:LandBuildings2016-09-30SC053605ns5:PlantMachinery2016-09-30SC053605ns5:CostValuation2016-09-30SC053605ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-09-30SC053605ns5:CurrentFinancialInstrumentsns5:WithinOneYear2016-09-30SC053605ns10:OrdinaryShareClass12017-09-30


REGISTERED NUMBER: SC053605 (Scotland)














UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 30 SEPTEMBER 2017

FOR

A & E CERESA LIMITED

A & E CERESA LIMITED (REGISTERED NUMBER: SC053605)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4

Chartered Accountants' Report 8

A & E CERESA LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 30 SEPTEMBER 2017







DIRECTORS: Mr E G Ceresa BSc.(Hons)M.R.Pharms
Mrs ME Ceresa BSc (Hons)
Ms G C T Ceresa BSc(Hons) M.R.Pharms
Ms ES Ceresa BSc(Hons)M.R.Pharms
Dr. CC Ceresa M.B. CH.B.
Dr S M Ceresa M.B.Ch.B



SECRETARY: Mr E G Ceresa BSc.(Hons)M.R.Pharms



REGISTERED OFFICE: 140 Cumbernauld Road
Stepps
Glasgow
Lanarkshire
G33 6HA



REGISTERED NUMBER: SC053605 (Scotland)



ACCOUNTANTS: D M McNaught & Co Ltd
Chartered Accountants
166 Buchanan Street
Glasgow
Lanarkshire
G1 2LW



BANKERS: The Royal Bank of Scotland plc
Glasgow City Branch (A)
10 Gordon Street
Glasgow
G1 3PL

A & E CERESA LIMITED (REGISTERED NUMBER: SC053605)

BALANCE SHEET
30 SEPTEMBER 2017

2017 2016
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 4 - -
Tangible assets 5 87,880 91,120
Investments 6 169,219 169,219
Investment property 7 320,000 320,000
577,099 580,339

CURRENT ASSETS
Stocks 72,358 51,116
Debtors 8 103,233 89,464
Cash at bank and in hand 202,229 208,505
377,820 349,085
CREDITORS
Amounts falling due within one year 9 161,930 125,989
NET CURRENT ASSETS 215,890 223,096
TOTAL ASSETS LESS CURRENT
LIABILITIES

792,989

803,435

PROVISIONS FOR LIABILITIES 35,873 35,873
NET ASSETS 757,116 767,562

CAPITAL AND RESERVES
Called up share capital 10 100 100
Other reserves 5,000 5,000
Retained earnings 752,016 762,462
SHAREHOLDERS' FUNDS 757,116 767,562

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 30 September 2017.

The members have not required the company to obtain an audit of its financial statements for the year ended 30 September 2017 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

A & E CERESA LIMITED (REGISTERED NUMBER: SC053605)

BALANCE SHEET - continued
30 SEPTEMBER 2017


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors on 15 March 2018 and were signed on its behalf by:





Mr E G Ceresa BSc.(Hons)M.R.Pharms - Director


A & E CERESA LIMITED (REGISTERED NUMBER: SC053605)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 SEPTEMBER 2017


1. STATUTORY INFORMATION

A & E Ceresa Limited is a private company, limited by shares , registered in Scotland. The company's registered
number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention as modified by the revaluation of certain assets.

Turnover
Turnover represents the total of medical prescriptions received from NHS Scotland and cash sales , less VAT.

Intangible assets
Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost
less any accumulated amortisation and any accumulated impairment losses.

Patents and licences are being amortised evenly over their estimated useful life of nil years.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Land and buildings - 2% on cost
Plant and machinery etc - 15% on reducing balance

Investment property
Investment property is shown at most recent valuation. Any aggregate surplus or deficit arising from changes in
fair value is recognised in profit or loss.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to
the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or
substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from
those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that
have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the
timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they
will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

A & E CERESA LIMITED (REGISTERED NUMBER: SC053605)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2017


2. ACCOUNTING POLICIES - continued

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to profit or loss in the period to which they relate.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 .

4. INTANGIBLE FIXED ASSETS
Other
intangible
assets
£   
COST
At 1 October 2016
and 30 September 2017 20,392
AMORTISATION
At 1 October 2016
and 30 September 2017 20,392
NET BOOK VALUE
At 30 September 2017 -
At 30 September 2016 -

5. TANGIBLE FIXED ASSETS
Plant and
Land and machinery
buildings etc Totals
£    £    £   
COST
At 1 October 2016
and 30 September 2017 106,798 99,205 206,003
DEPRECIATION
At 1 October 2016 23,078 91,805 114,883
Charge for year 2,130 1,110 3,240
At 30 September 2017 25,208 92,915 118,123
NET BOOK VALUE
At 30 September 2017 81,590 6,290 87,880
At 30 September 2016 83,720 7,400 91,120

A & E CERESA LIMITED (REGISTERED NUMBER: SC053605)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2017


6. FIXED ASSET INVESTMENTS
Other
investments
£   
COST
At 1 October 2016
and 30 September 2017 169,219
NET BOOK VALUE
At 30 September 2017 169,219
At 30 September 2016 169,219

7. INVESTMENT PROPERTY
Total
£   
FAIR VALUE
At 1 October 2016
and 30 September 2017 320,000
NET BOOK VALUE
At 30 September 2017 320,000
At 30 September 2016 320,000

Fair value at 30 September 2017 is represented by:

£   
Valuation in 2017 211,018
Cost 108,982
320,000

If investment property had not been revalued it would have been included at the following historical cost:

2017 2016
£    £   
Cost 108,982 108,982

Investment property was valued on an open market basis on 30 September 2017 by the directors .

8. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Trade debtors 90,942 79,957
Other debtors 12,291 9,507
103,233 89,464

A & E CERESA LIMITED (REGISTERED NUMBER: SC053605)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 30 SEPTEMBER 2017


9. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2017 2016
£    £   
Bank loans and overdrafts 56,707 43,407
Trade creditors 79,403 63,570
Taxation and social security 15,820 18,609
Other creditors 10,000 403
161,930 125,989

10. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2017 2016
value: £    £   
100 Ordinary £1 100 100

11. ULTIMATE CONTROLLING PARTY

The controlling party is Mr E G Ceresa BSc.(Hons)M.R.Pharms.

CHARTERED ACCOUNTANTS' REPORT TO THE BOARD OF DIRECTORS
ON THE UNAUDITED FINANCIAL STATEMENTS OF
A & E CERESA LIMITED


The following reproduces the text of the report prepared for the directors in respect of the company's annual
unaudited financial statements. In accordance with the Companies Act 2006, the company is only required to file
a Balance Sheet. Readers are cautioned that the Income Statement and certain other primary statements and the
Report of the Directors are not required to be filed with the Registrar of Companies.

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the
financial statements of A & E Ceresa Limited for the year ended 30 September 2017 which comprise the Income
Statement, Balance Sheet and the related notes from the company's accounting records and from information and
explanations you have given us.

As a practising member firm of ICAS, we are subject to its ethical and other professional requirements which are detailed at http://www.icas.com/accountspreparationguidance.

This report is made solely to the Board of Directors of A & E Ceresa Limited, as a body, in accordance with our terms of engagement. Our work has been undertaken solely to prepare for your approval the financial statements of A & E Ceresa Limited and state those matters that we have agreed to state to the Board of Directors of A & E Ceresa Limited, as a body, in this report in accordance with the requirements of ICAS as detailed at http://www.icas.com/accountspreparationguidance. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and its Board of Directors, as a body, for our work or for this report.

It is your duty to ensure that A & E Ceresa Limited has kept adequate accounting records and to prepare statutory financial statements that give a true and fair view of the assets, liabilities, financial position and profit of A & E Ceresa Limited. You consider that A & E Ceresa Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the financial statements of A & E Ceresa Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory financial statements.






D M McNaught & Co Ltd
Chartered Accountants
166 Buchanan Street
Glasgow
Lanarkshire
G1 2LW


16 March 2018